1. Home
  2. CBL vs STOK Comparison

CBL vs STOK Comparison

Compare CBL & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CBL & Associates Properties Inc.

CBL

CBL & Associates Properties Inc.

HOLD

Current Price

$53.90

Market Cap

1.7B

Sector

Real Estate

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$28.39

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBL
STOK
Founded
1978
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
CBL
STOK
Price
$53.90
$28.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$45.00
$39.20
AVG Volume (30 Days)
179.7K
678.1K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
4.00%
N/A
EPS Growth
132.09
92.73
EPS
2.95
N/A
Revenue
$578,373,000.00
$184,420,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$77.49
P/E Ratio
$18.26
N/A
Revenue Growth
12.18
404.50
52 Week Low
$28.05
$20.32
52 Week High
$60.40
$40.22

Technical Indicators

Market Signals
Indicator
CBL
STOK
Relative Strength Index (RSI) 42.80 38.77
Support Level $53.64 $28.02
Resistance Level $55.88 $33.61
Average True Range (ATR) 1.28 1.21
MACD -0.15 -0.25
Stochastic Oscillator 42.76 17.50

Price Performance

Historical Comparison
CBL
STOK

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: